Shares of Savient Pharmaceuticals Inc. (SVNT) climbed throughout the first hour of Wednesday's session, but traded in a range for the remainder of the day. The stock closed up by $0.66 at $13.09.
Savient Pharmaceuticals Inc. rose above a narrow, one-week range Wednesday and closed at an 8-month high. The stock has experienced a surge in volume and share price in the last 2 weeks, following an FDA review of studies of the company's gout drug Krystexxa.
For comments and feedback: editorial@rttnews.com